Alvotech (NASDAQ:ALVOW – Get Free Report) traded up 37% during trading on Thursday. The stock traded as high as $0.3799 and last traded at $0.37. Approximately 2,350 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 4,478 shares. The stock had previously closed at $0.27.
Alvotech Stock Performance
The stock has a fifty day simple moving average of $0.26 and a two-hundred day simple moving average of $0.25.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Stories
- Five stocks we like better than Alvotech
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
- Best Buy Is Turning Amazon Fire TV Into a New Advertising Opportunity
- MarketBeat Week in Review – 09/21 – 09/25
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
